Pacer Advisors, Inc. Bio N Tech Se Transaction History

Pacer Advisors, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$80.36 - $102.87 $160 - $205	2 Added 0.18%	1,105 $88,000
Q1 2024 May 10, 2024	SELL	$88.96 - $112.35 $2,490 - $3,145	-28 Reduced 2.48%	1,103 $101,000
Q4 2023 Jan 16, 2024	SELL	$90.91 - $112.75 $2,090 - $2,593	-23 Reduced 1.99%	1,131 $119,000
Q3 2023 Nov 13, 2023	BUY	$98.5 - $125.08 $4,137 - $5,253	42 Added 3.78%	1,154 $125,000
Q2 2023 Jul 12, 2023	BUY	$102.58 - $129.66 $8,411 - $10,632	82 Added 7.96%	1,112 $120,000
Q1 2023 May 02, 2023	BUY	$122.57 - $153.67 $2,573 - $3,227	21 Added 2.08%	1,030 $128,000
Q4 2022 Feb 06, 2023	BUY	$118.43 - $186.05 $74,018 - $116,281	625 Added 162.76%	1,009 $151,000
Q3 2022 Oct 18, 2022	SELL	$127.65 - $183.11 $16,211 - $23,254	-127 Reduced 24.85%	384 $52,000
Q2 2022 Aug 12, 2022	BUY	$123.25 - $186.24 $862 - $1,303	7 Added 1.39%	511 $76,000
Q1 2022 Apr 05, 2022	SELL	$126.25 - $231.85 $95,571 - $175,510	-757 Reduced 60.03%	504 $86,000
Q4 2021 Feb 03, 2022	BUY	$216.64 - $362.52 $72,357 - $121,081	334 Added 36.03%	1,261 $325,000
Q3 2021 Oct 15, 2021	BUY	$205.93 - $447.23 $121,292 - $263,418	589 Added 174.26%	927 $253,000
Q2 2021 Jul 21, 2021	BUY	$113.32 - $241.49 $38,302 - $81,623	338 New	338 $76,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.